Medicine for treating rheumatoid arthritis

Abstract

The invention belongs to the field of traditional Chinese medicine preparations and provides medicine for treating rheumatoid arthritis. The medicine is prepared from ephedra herbs, radix paeoniae alba, astragali radix, cassis twigs, radix clematidis, radix rehmanniae preparata, ligusticum wallichii, radix angelica sinensis, radix gentianae macrophyllae, rhizoma et radix notopterygii, radix achyranthis bidentatae and parasitic loranthus. The medicine has the advantages that the medicine materials are easy to obtain, the preparing technology is simple, and the efficacy is remarkable.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine preparations, in particular to a medicine for treating rheumatoid arthritis. Background technique [0002] The etiology of rheumatoid arthritis is not very clear so far. At present, it is mostly considered to be an autoimmune disease of the human body, and it can also be regarded as a chronic syndrome, manifested as non-specific inflammation of peripheral joints. At this time, the diseased joint and its surrounding tissues show progressive destruction, and cause dysfunction of the damaged joint. The incidence rate of rheumatoid arthritis in women is higher than that in men, and women are 2 to 3 times that of men; the incidence rate in European and American countries is significantly higher than that in Chinese. [0003] Doctor trained in Western medicine uses drugs such as glucocorticoids, immunosuppressants, and the therapeutic effect is unsatisfactory, and has toxic side effect, can ...

AI Technical Summary

Problems solved by technology

[0003] Western medicine uses glucocorticoids, immunosuppressants and other drugs, the treatment effect is not satisfactory, and there are toxic side effects, so it cannot be used for a long time

Images